Biomet Inc. Announces the Successful Introduction of Signature™ Patient-Specific Glenoid Instrumentation in the United States

Published: Sep 05, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WARSAW, Ind.--(BUSINESS WIRE)--Biomet Orthopedics, LLC, a global leader in the manufacture of orthopedic and biotechnology products, today announced the first clinical use of the Signature™ Patient-Specific glenoid instrumentation in the United States. The Signature™ Glenoid System was introduced in Europe in February 2013, and is used in conjunction with Biomet's Comprehensive® shoulder system, the market-leading shoulder replacement system in the United States. Signature™ glenoid guides utilize CT data and a proprietary algorithm to match each patient's anatomy and facilitate proper positioning of the glenoid component. The preoperative planning tool allows surgeons to make any necessary adjustments required for each patient, including component size, inclination, and version, prior to surgery.

Help employers find you! Check out all the jobs and post your resume.

Back to news